EVE 0.00% 0.1¢ eve health group limited.

Ann: Appendix 4D and Half Year Report, page-2

  1. 5,245 Posts.
    lightbulb Created with Sketch. 737
    "Revenue in contract
    manufacturing was impacted negatively by installation of new equipment early in the period while
    sales of branded products, which grew 37% on the prior corresponding period, was still lower than
    forecast
    and shipping costs were higher and delivery times were longer. While the Company still
    expects strong growth in markets such as Australia, USA and Japan for branded product sales in
    future periods, the above factors have led to the Company recognising an impairment loss of
    $825,059 on the Meluka CGU in the period."


    oh dear.

    Also revenue down compared to 2020, wheres Gops and his "explosive growth" posts? lol.
    Last edited by ExtremeLand: 28/02/22
 
watchlist Created with Sketch. Add EVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.